Association of a Novel Human Immunodeficiency Virus Type 1 Protease Substrate Cleft Mutation, L23I, With Protease Inhibitor Therapy and in Vitro Drug Resistance
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.48.12.4864-4868.2004
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2004
Authors
Publisher
American Society for Microbiology